Literature DB >> 23173839

Sleep-Wake profiles in patients with primary biliary cirrhosis.

Sara Montagnese1, Letizia M Nsemi, Nora Cazzagon, Silvia Facchini, Laura Costa, Nora V Bergasa, Piero Amodio, Annarosa Floreani.   

Abstract

BACKGROUND: Impaired sleep quality and daytime sleepiness have been described in patients with primary biliary cirrhosis (PBC). However, no information is available on their sleep timing/diurnal preference. AIMS: To evaluate such variables and determine their relationship with sleep quality, fatigue, pruritus and quality of life.
METHODS: Seventy-four patients with PBC (58 ± 12 years), 79 healthy volunteers (56 ± 8 years) and 60 patients with cirrhosis (58 ± 12 years) underwent formal assessment of sleep quality/timing, diurnal preference and daytime sleepiness. Patients with PBC also underwent assessment of fatigue, quality of life and the daytime course of sleepiness/pruritus.
RESULTS: Sleep timing was significantly delayed in both patients with PBC and with cirrhosis, compared to healthy volunteers (sleep onset time: 23:18 ± 01:00 vs. 23:30 ± 01:00 vs. 22:54 ± 00:54 hours, respectively; P < 0.05). In patients with PBC, delayed sleep timing was associated with impaired sleep quality (P < 0.05). Sleepiness showed a physiological daily rhythm, with early afternoon/evening peaks. Pruritus was absent in the morning and increased over the afternoon/evening hours. Both the daytime course of pruritus and sleepiness changed in relation to diurnal preference. Patients with PBC and significant pruritus (upper quartile) had prolonged sleep latency (39 ± 37 vs. 21 ± 23 min, P = 0.05) and earlier wake-up times (5.9 ± 0.8 vs. 6.7 ± 0.9 min, P < 0.05). Significant correlations were observed between sleep timing and quality of life.
CONCLUSIONS: Patients with PBC exhibited a delay in sleep timing that was associated with impaired sleep quality/quality of life. In addition, an interplay was observed between diurnal preference and the daytime course of pruritus/sleepiness.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 23173839     DOI: 10.1111/liv.12026

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

1.  Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Authors:  Nan Wu; Fanyin Meng; Tianhao Zhou; Yuyan Han; Lindsey Kennedy; Julie Venter; Heather Francis; Sharon DeMorrow; Paolo Onori; Pietro Invernizzi; Francesca Bernuzzi; Romina Mancinelli; Eugenio Gaudio; Antonio Franchitto; Shannon Glaser; Gianfranco Alpini
Journal:  FASEB J       Date:  2017-06-20       Impact factor: 5.191

2.  Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury.

Authors:  Nan Wu; Guido Carpino; Ludovica Ceci; Leonardo Baiocchi; Heather Francis; Lindsey Kennedy; Tianhao Zhou; Lixian Chen; Keisaku Sato; Konstantina Kyritsi; Vik Meadows; Burcin Ekser; Antonio Franchitto; Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2021-11-24       Impact factor: 17.425

Review 3.  Management of pruritus in chronic liver disease.

Authors:  Angeline Bhalerao; Gurdeep S Mannu
Journal:  Dermatol Res Pract       Date:  2015-03-10

Review 4.  Managing Sleep Disturbances in Cirrhosis.

Authors:  Xun Zhao; Philip Wong
Journal:  Scientifica (Cairo)       Date:  2016-05-03

5.  Polymorphisms of IL12RB2 May Affect the Natural History of Primary Biliary Cholangitis: A Single Centre Study.

Authors:  Urszula Wasik; Ewa Wunsch; Gary L Norman; Eirini I Rigopoulou; Dimitrios P Bogdanos; Piotr Milkiewicz; Małgorzata Milkiewicz
Journal:  J Immunol Res       Date:  2017-02-19       Impact factor: 4.818

6.  A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis.

Authors:  Marlyn J Mayo; Paul J Pockros; David Jones; Christopher L Bowlus; Cynthia Levy; Imran Patanwala; Bruce Bacon; Velimir Luketic; Raj Vuppalanchi; Sharon Medendorp; Alejandro Dorenbaum; Ciara Kennedy; Patricia Novak; Joan Gu; George Apostol; Gideon M Hirschfield
Journal:  Hepatol Commun       Date:  2019-02-01

Review 7.  Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease.

Authors:  Oana-Mihaela Plotogea; Madalina Ilie; Simona Bungau; Alexandru Laurentiu Chiotoroiu; Ana Maria Alexandra Stanescu; Camelia Cristina Diaconu
Journal:  Brain Sci       Date:  2021-01-22

Review 8.  Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies.

Authors:  Keisaku Sato; Fanyin Meng; Heather Francis; Nan Wu; Lixian Chen; Lindsey Kennedy; Tianhao Zhou; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  J Pineal Res       Date:  2020-03-04       Impact factor: 13.007

Review 9.  Assessment and Management of Sleep Disturbance in Cirrhosis.

Authors:  Chiara Formentin; Maria Garrido; Sara Montagnese
Journal:  Curr Hepatol Rep       Date:  2018-02-13

10.  Morning Bright Light Treatment for Sleep-Wake Disturbances in Primary Biliary Cholangitis: A Pilot Study.

Authors:  Matteo Turco; Nora Cazzagon; Irene Franceschet; Chiara Formentin; Giovanni Frighetto; Francesca Giordani; Nicola Cellini; Gabriella Mazzotta; Rodolfo Costa; Benita Middleton; Debra J Skene; Annarosa Floreani; Sara Montagnese
Journal:  Front Physiol       Date:  2018-11-05       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.